A

Arrowhead Pharmaceuticals
D

ARWR

63.135
USD
-0.70
(-1.09%)
مغلق
حجم التداول
49,532
الربح لكل سهم
-1
العائد الربحي
-
P/E
39
حجم السوق
8,840,932,316
أصول ذات صلة المقالات

العنوان: Arrowhead Pharmaceuticals

القطاع: Healthcare
الصناعة: Biotechnology
Arrowhead Pharmaceuticals Inc is an American biotechnology company. Its main target is the development of medicine to treat diseases with a genetic origin, characterized by the overproduction of one or more proteins. Its medical solutions are aimed at the genes that trigger the diseases. Its portfolio includes drugs targeting cardiovascular, Cardiometabolic, Central Nervous System, Pulmonary, Liver, Muscular, and Complement Mediated Disease. It majority products are liver disease curable.